Medical device and MedTech insights, news, tips and more

Arterys Raises $28 Million to Accelerate the Delivery of Medical AI to Practices Around the World

June 2, 2020

Arterys Logo

Arterys, a leading global medical imaging platform to deliver clinical AI products over the internet, just received its seventh USA FDA clearance and announced its latest round of funding — a $28 million Series C investment from a syndicate led by Benslie Investment Group and Temasek Holdings, with participation by Fosun, Revelation Partners, Emergent Medical Partners, and Varian Medical Systems.

Arterys Logo

Arterys said it will deploy this new round of financing to broaden the Arterys ecosystem, comprising a broad set of partners on the new Arterys Marketplace working together to deliver clinical applications built on the Arterys cloud-native viewer and platform. A particular focus will be to accelerate partners’ efforts to bring new clinical-grade AI applications to providers by extending its proprietary technology platform to application partners thereby making it easier for clinicians to integrate AI into their workflows from a single interface.

“The current crisis has shown us the necessity of a different approach to providing healthcare, where technology and AI are crucial for future success. Arterys is committed to transforming the way AI is integrated into the medical workflow, a promise that is long due in the industry. We recently launched our cloud platform and marketplace that will consolidate the work of thousands of AI models to be readily available for use by healthcare institutions around the globe,” said Henry Weinstein, Managing Partner at Benslie International Ltd.

Arterys has appointed John Axerio-Cilies, co-founder, as the acting CEO. “We realize that we can’t transform the healthcare system alone,” says Axerio-Cilies. “No company can. And now, the same technology and strengths that we’ve leveraged to build our core products [Arterys Cardio AI and Arterys Lung AI] are now available to medical innovators at companies and universities around the world — they can benefit from regulatory support, channel partnerships, performance, security, and best-in-class hospital system integrations.”

See Full Press Release: Arterys Raises $28 Million to Accelerate the Delivery of Medical AI to Practices Around the World | Newswire


Written by: Arterys


Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?

Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.